Ledger.Open graph →
SEC Form D · Amendment · filed July 15, 2009

Aegerion Pharmaceuticals, Inc

Offering
$15.8M
Sold
$13.6M
Exemption
—
Industry
Pharmaceuticals
Location
BRIDGEWATER, NJ
Type
—

People & firms on this filing (19)

Michele Ollier · Bridgewater, NJDirectorDavid Scheer · Bridgewater, NJDirectorAntonio M. Gotto · Bridgewater, NJDirectorPeter Garrambone · Bridgewater, NJDirectorWilliam Sasiela · Bridgewater, NJExecWilliam H. Lewis · Bridgewater, NJExecAlison De Bord · Bridgewater, NJDirectorJason Fisherman · Bridgewater, NJDirectorChristine Pellizzari · Bridgewater, NJExecMichael Finney · Boston, MAExecAlf Bjorseth · Oslo, Q8ExecBjorge Gretland · Oslo, Q8ExecMike Janse · Palo Alto, CADirectorAl Schuele · Dallas, TXDirectorPaul Vais · Menlo Park, CADirectorClinton Bybee · Chicago, ILDirectorKevin Kent · Irvine, CADirectorBruce A. Brown · Kennesaw, GADirectorDavid Arkowitz · Bridgewater, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗